Safety and Pharmacokinetics of Ascending Single Oral Doses of EDP-322 in Nonfasting and Fasting Healthy Volunteers

NCT00989872 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin and Soft Tissue Infections
Methicillin-resistant Staphylococcus Aureus

Interventions

DRUG: EDP-322

Sponsor

Enanta Pharmaceuticals, Inc